Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology
The nematode Caenorhabditis elegans has emerged as an important animal model in
various fields including neurobiology, developmental biology, and genetics. Characteristics …
various fields including neurobiology, developmental biology, and genetics. Characteristics …
α-Synuclein: membrane interactions and toxicity in Parkinson's disease
PK Auluck, G Caraveo… - Annual review of cell and …, 2010 - annualreviews.org
In the late 1990s, mutations in the synaptic protein α-synuclein (α-syn) were identified in
families with hereditary Parkinson's disease (PD). Rapidly, α-syn became the target of …
families with hereditary Parkinson's disease (PD). Rapidly, α-syn became the target of …
Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases
Advances in research and technology has increased our quality of life, allowed us to combat
diseases, and achieve increased longevity. Unfortunately, increased longevity is …
diseases, and achieve increased longevity. Unfortunately, increased longevity is …
Delaying aging and the aging-associated decline in protein homeostasis by inhibition of tryptophan degradation
AT Van Der Goot, W Zhu… - Proceedings of the …, 2012 - pnas.org
Toxicity of aggregation-prone proteins is thought to play an important role in aging and age-
related neurological diseases like Parkinson and Alzheimer's diseases. Here, we identify …
related neurological diseases like Parkinson and Alzheimer's diseases. Here, we identify …
Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease
Polypharmacology-based strategies using drug combinations with different mechanisms of
action are gaining increasing attention as a novel methodology to discover potentially …
action are gaining increasing attention as a novel methodology to discover potentially …
Genetics and epigenetics of Parkinson′ s disease
F Coppedè - The Scientific World Journal, 2012 - Wiley Online Library
In 1997 a mutation in the a-synuclein (SNCA) gene was associated with familial autosomal
dominant Parkinson's disease (PD). Since then, several loci (PARK1‐15) and genes have …
dominant Parkinson's disease (PD). Since then, several loci (PARK1‐15) and genes have …
Modeling neurodegenerative diseases in Caenorhabditis elegans
J Li, W Le - Experimental neurology, 2013 - Elsevier
Neurodegenerative diseases which include Alzheimer's disease (AD), Parkinson's disease
(PD), amyotrophic lateral sclerosis (ALS), Huntington disease (HD), and others are …
(PD), amyotrophic lateral sclerosis (ALS), Huntington disease (HD), and others are …
[HTML][HTML] Neurodegeneration and epigenetics: A review
P Ghosh, A Saadat - Neurología (English Edition), 2023 - Elsevier
Neuronal function and differentiation are tightly regulated by both genome and epigenome.
Based on the environmental information the epigenetic changes occur. Neurodegeneration …
Based on the environmental information the epigenetic changes occur. Neurodegeneration …
Epigenetics in Parkinson's disease
MAS Pavlou, TF Outeiro - Neuroepigenomics in aging and disease, 2017 - Springer
Parkinson's disease (PD) is a highly complex neurodegenerative disorder with a
multifactorial origin. Although several cellular mechanisms and genes have been implicated …
multifactorial origin. Although several cellular mechanisms and genes have been implicated …
The glycolytic enzyme, GPI, is a functionally conserved modifier of dopaminergic neurodegeneration in Parkinson's models
AL Knight, X Yan, S Hamamichi, RR Ajjuri, JR Mazzulli… - Cell metabolism, 2014 - cell.com
Neurodegenerative diseases represent an increasing burden in our aging society, yet the
underlying metabolic factors influencing onset and progression remain poorly defined. The …
underlying metabolic factors influencing onset and progression remain poorly defined. The …